245
Participants
Start Date
July 14, 2020
Primary Completion Date
August 31, 2027
Study Completion Date
August 31, 2027
Linerixibat
All participants will receive linerixibat.
GSK Investigational Site, Ciudad AutOnoma de Buenos Aire
GSK Investigational Site, Sofia
GSK Investigational Site, Santa Fe
GSK Investigational Site, New York
GSK Investigational Site, Mexico City
GSK Investigational Site, Philadelphia
GSK Investigational Site, Milan
GSK Investigational Site, Monza
GSK Investigational Site, Morrisville
GSK Investigational Site, Durham
GSK Investigational Site, Madrid
GSK Investigational Site, Madrid
GSK Investigational Site, Pilsen
GSK Investigational Site, Miami
GSK Investigational Site, Haifa
GSK Investigational Site, Padua
GSK Investigational Site, Negrar Verona
GSK Investigational Site, Seville
GSK Investigational Site, Modena
GSK Investigational Site, Valencia
GSK Investigational Site, Münster
GSK Investigational Site, Detroit
GSK Investigational Site, Holon
GSK Investigational Site, Lille
GSK Investigational Site, Monterrey
GSK Investigational Site, Dallas
GSK Investigational Site, Rehovot
GSK Investigational Site, Houston
GSK Investigational Site, Napoli
GSK Investigational Site, West Hollywood
GSK Investigational Site, Palermo
GSK Investigational Site, Erlangen
GSK Investigational Site, Jerusalem
GSK Investigational Site, Davis
GSK Investigational Site, Seattle
GSK Investigational Site, Beijing
GSK Investigational Site, Beijing
GSK Investigational Site, Moscow
GSK Investigational Site, Changchun
GSK Investigational Site, Shanghai
GSK Investigational Site, Nanjing
GSK Investigational Site, Tianjin
GSK Investigational Site, Nanchang
GSK Investigational Site, Chongqing
GSK Investigational Site, Samara
GSK Investigational Site, Guangzhou
GSK Investigational Site, Kemerovo
GSK Investigational Site, Botucatu
GSK Investigational Site, Porto Alegre
GSK Investigational Site, Buenos Aires
GSK Investigational Site, Capital Federal
GSK Investigational Site, Ciudad Autonoma de Bueno
GSK Investigational Site, Rosario
GSK Investigational Site, Brasília
GSK Investigational Site, Salvador
GSK Investigational Site, Edmonton
GSK Investigational Site, Toronto
GSK Investigational Site, Prague
GSK Investigational Site, Roma
GSK Investigational Site, Chiba
GSK Investigational Site, Ehime
GSK Investigational Site, Fukui
GSK Investigational Site, Gunma
GSK Investigational Site, Hiroshima
GSK Investigational Site, Hiroshima
GSK Investigational Site, Hokkaido
GSK Investigational Site, Kagawa
GSK Investigational Site, Kanagawa
GSK Investigational Site, Nagano
GSK Investigational Site, Nagasaki
GSK Investigational Site, Nara
GSK Investigational Site, Osaka
GSK Investigational Site, Osaka
GSK Investigational Site, Shizuoka
GSK Investigational Site, Tokyo
GSK Investigational Site, Tokyo
GSK Investigational Site, Tokyo
GSK Investigational Site, Tokyo
GSK Investigational Site, Mexico City
GSK Investigational Site, Częstochowa
GSK Investigational Site, Katowice
GSK Investigational Site, Mysłowice
GSK Investigational Site, Warsaw
GSK Investigational Site, Wroclaw
GSK Investigational Site, Barcelona
GSK Investigational Site, Basingstoke
GSK Investigational Site, Glasgow
GSK Investigational Site, Hull
GSK Investigational Site, London
GSK Investigational Site, Newcastle upon Tyne
GSK Investigational Site, Nottingham
GSK Investigational Site, Plymouth
GSK Investigational Site, Reading Berkshire
GSK Investigational Site, Southampton
GSK Investigational Site, Surrey
Lead Sponsor
GlaxoSmithKline
INDUSTRY